328 related articles for article (PubMed ID: 6838067)
1. Staphylococcus epidermidis causing prosthetic valve endocarditis: microbiologic and clinical observations as guides to therapy.
Karchmer AW; Archer GL; Dismukes WE
Ann Intern Med; 1983 Apr; 98(4):447-55. PubMed ID: 6838067
[TBL] [Abstract][Full Text] [Related]
2. Rifampin treatment of prosthetic valve endocarditis due to Staphylococcus epidermidis.
Karchmer AW; Archer GL; Dismukes WE
Rev Infect Dis; 1983; 5 Suppl 3():S543-8. PubMed ID: 6556711
[TBL] [Abstract][Full Text] [Related]
3. Staphylococcal endocarditis. Laboratory and clinical basis for antibiotic therapy.
Karchmer AW
Am J Med; 1985 Jun; 78(6B):116-27. PubMed ID: 3893113
[TBL] [Abstract][Full Text] [Related]
4. Prosthetic valve endocarditis due to methicillin-resistant Staphylococcus epidermidis and Micrococcus species successfully treated with rifampicin combined with other antibiotics.
Colebunders R; Ursi JP; Pattyn S; Snoeck J
J Infect; 1985 Jul; 11(1):35-9. PubMed ID: 3875661
[TBL] [Abstract][Full Text] [Related]
5. Prosthetic valve endocarditis caused by Staphylococcus epidermidis. Development of rifampin resistance during vancomycin and rifampin therapy.
Chamovitz B; Bryant RE; Gilbert DN; Hartstein AI
JAMA; 1985 May; 253(19):2867-8. PubMed ID: 3989962
[TBL] [Abstract][Full Text] [Related]
6. Methicillin-resistant Staphylococcus aureus prosthetic aortic valve endocarditis with paravalvular abscess treated with daptomycin.
Mohan SS; McDermott BP; Cunha BA
Heart Lung; 2005; 34(1):69-71. PubMed ID: 15647736
[TBL] [Abstract][Full Text] [Related]
7. [A case report of active aortic prosthetic valve endocarditis due to methicillin-resistant Staphylococcus epidermidis].
Asakura T; Aoki K; Tadokoro M; Tanaka H; Furuta S
Nihon Kyobu Geka Gakkai Zasshi; 1996 Aug; 44(8):1185-92. PubMed ID: 8828382
[TBL] [Abstract][Full Text] [Related]
8. [Aminoglycosides in the treatment of infectious endocarditis].
Malinverni R
Schweiz Med Wochenschr Suppl; 1996; 76():14S-20S. PubMed ID: 8677414
[TBL] [Abstract][Full Text] [Related]
9. Combination antibiotic therapy in an outbreak of prosthetic endocarditis caused by Staphylococcus epidermidis.
Hammond GW; Stiver HG
Can Med Assoc J; 1978 Mar; 118(5):524-30. PubMed ID: 343904
[TBL] [Abstract][Full Text] [Related]
10. Therapy of methicillin-resistant Staphylococcus epidermidis experimental endocarditis.
Lowy FD; Wexler MA; Steigbigel NH
J Lab Clin Med; 1982 Jul; 100(1):94-104. PubMed ID: 6919570
[TBL] [Abstract][Full Text] [Related]
11. Teicoplanin compared with vancomycin for treatment of experimental endocarditis due to methicillin-resistant Staphylococcus epidermidis.
Galetto DW; Boscia JA; Kobasa WD; Kaye D
J Infect Dis; 1986 Jul; 154(1):69-75. PubMed ID: 2940303
[TBL] [Abstract][Full Text] [Related]
12. Ciprofloxacin therapy of experimental endocarditis caused by methicillin-resistant Staphylococcus epidermidis.
Rouse MS; Wilcox RM; Henry NK; Steckelberg JM; Wilson WR
Antimicrob Agents Chemother; 1990 Feb; 34(2):273-6. PubMed ID: 2327776
[TBL] [Abstract][Full Text] [Related]
13. Gentamicin may have no effect on mortality of staphylococcal prosthetic valve endocarditis.
Ramos-Martínez A; Muñoz Serrano A; de Alarcón González A; Muñoz P; Fernández-Cruz A; Valerio M; Fariñas MC; Gutiérrez-Cuadra M; Miró JM; Ruiz-Morales J; Sousa-Regueiro D; Montejo JM; Gálvez-Acebal J; HidalgoTenorio C; Domínguez F;
J Infect Chemother; 2018 Jul; 24(7):555-562. PubMed ID: 29628387
[TBL] [Abstract][Full Text] [Related]
14. Long term follow up of prosthetic valve endocarditis: what characteristics identify patients who were treated successfully with antibiotics alone?
Truninger K; Attenhofer Jost CH; Seifert B; Vogt PR; Follath F; Schaffner A; Jenni R
Heart; 1999 Dec; 82(6):714-20. PubMed ID: 10573500
[TBL] [Abstract][Full Text] [Related]
15. Endocarditis associated with prosthetic cardiac valves.
Chen SC; Sorrell TC; Dwyer DE; Collignon PJ; Wright EJ
Med J Aust; 1990 May; 152(9):458, 461-3. PubMed ID: 2381336
[TBL] [Abstract][Full Text] [Related]
16. Native valve endocarditis due to coagulase-negative staphylococci. Clinical and microbiologic features.
Caputo GM; Archer GL; Calderwood SB; DiNubile MJ; Karchmer AW
Am J Med; 1987 Oct; 83(4):619-25. PubMed ID: 3674050
[TBL] [Abstract][Full Text] [Related]
17. Rifampin therapy of Staphylococcus epidermidis. Use in infections from indwelling artificial devices.
Archer GL; Tenenbaum MJ; Haywood HB
JAMA; 1978 Aug; 240(8):751-3. PubMed ID: 671704
[TBL] [Abstract][Full Text] [Related]
18. Antibiotic prophylaxis and prosthetic valve endocarditis.
Antunes MJ; Sanches MF; Fernandes LE
J Heart Valve Dis; 1992 Nov; 1(2):201-5. PubMed ID: 1341628
[TBL] [Abstract][Full Text] [Related]
19. Role of glycopeptides in the treatment of septic complications after cardiac surgery.
Bourgoin A; Léone M; Martin C
J Chemother; 2001 Nov; 13 Spec No 1(1):112-8. PubMed ID: 11936353
[TBL] [Abstract][Full Text] [Related]
20. Endocarditis caused by coagulase-negative staphylococci.
Williams DN; Peterson PK; Verhoef J; Laverdiere M; Sabath LD
Infection; 1979; 7(1):5-9. PubMed ID: 253687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
